Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Tick | Case report

Human granulocytic anaplasmosis combined with rhabdomyolysis: a case report

Authors: Jeong Min Cho, Jeonghyun Chang, Dong-Min Kim, Yee Gyung Kwak, Chong Rae Cho, Je Eun Song

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Human granulocytic anaplasmosis (HGA) is a systemic inflammatory response caused by the rickettsial bacterium Anaplasma phagocytophilum. Rhabdomyolysis and acute kidney injury (AKI) are rare complications of HGA. Here, we report a case of HGA concurrent with rhabdomyolysis and AKI in an elderly patient.

Case presentation

An 84-year old woman with a medical history of hypertension was hospitalised after two days of fever, dizziness, whole body pain, and general weakness. Laboratory investigations showed severe thrombocytopenia, leukopenia, impaired renal function, and elevated cardiac enzyme and myoglobin levels. On the day after admission, peripheral blood smear revealed morula inclusions in neutrophils, a suggestive finding of HGA. Real-time polymerase chain reaction (PCR) results indicated the presence of A. phagocytophilum. Antibiotics were de-escalated to doxycycline monotherapy. After 10 days of antibiotic treatment, laboratory tests showed complete recovery from HGA complicated with rhabdomyolysis and AKI.

Conclusions

HGA can lead to serious complications in patients with associated risk factors. Therefore, in patients with HGA accompanied by rhabdomyolysis, management with antibiotics and hydration should be initiated immediately, and not delayed until diagnostic confirmation.
Literature
1.
go back to reference Bakken JS, Dumler JS. Human granulocytic anaplasmosis. Infect Dis Clin North Am. 2015;29(2):341–55.CrossRef Bakken JS, Dumler JS. Human granulocytic anaplasmosis. Infect Dis Clin North Am. 2015;29(2):341–55.CrossRef
2.
go back to reference Kim KH, Yi J, Oh WS, Kim NH, Choi SJ, Choe PG, et al. Human granulocytic anaplasmosis, South Korea, 2013. Emerg Infect Dis. 2014;20(10):1708–11.CrossRef Kim KH, Yi J, Oh WS, Kim NH, Choi SJ, Choe PG, et al. Human granulocytic anaplasmosis, South Korea, 2013. Emerg Infect Dis. 2014;20(10):1708–11.CrossRef
3.
go back to reference Bakken JS, Dumler JS. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci. 2006;1078:236–47.CrossRef Bakken JS, Dumler JS. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci. 2006;1078:236–47.CrossRef
4.
go back to reference Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA. 1994;272(3):212–8.CrossRef Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA. 1994;272(3):212–8.CrossRef
5.
go back to reference Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, et al. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis—United States. MMWR Recomm Rep. 2016;65(2):1–44.CrossRef Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, et al. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis—United States. MMWR Recomm Rep. 2016;65(2):1–44.CrossRef
7.
go back to reference Yi J, Kim KH, Ko MK, Lee EY, Choi SJ, Oh MD. Human granulocytic anaplasmosis as a cause of febrile illness in Korea since at least 2006. Am J Trop Med Hyg. 2017;96(4):777–82.PubMedPubMedCentral Yi J, Kim KH, Ko MK, Lee EY, Choi SJ, Oh MD. Human granulocytic anaplasmosis as a cause of febrile illness in Korea since at least 2006. Am J Trop Med Hyg. 2017;96(4):777–82.PubMedPubMedCentral
8.
go back to reference Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007;45(Suppl 1):S45-51.CrossRef Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007;45(Suppl 1):S45-51.CrossRef
9.
go back to reference Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000;31(2):554–60.CrossRef Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000;31(2):554–60.CrossRef
10.
go back to reference Dahlgren FS, Mandel EJ, Krebs JW, Massung RF, McQuiston JH. Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000–2007. Am J Trop Med Hyg. 2011;85(1):124–31.CrossRef Dahlgren FS, Mandel EJ, Krebs JW, Massung RF, McQuiston JH. Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000–2007. Am J Trop Med Hyg. 2011;85(1):124–31.CrossRef
11.
go back to reference Boateng F, Ohene-Adjei R, Amoateng-Adjepong Y. Rhabdomyolysis and acute renal failure associated with human granulocytic anaplasmosis. Mayo Clin Proc. 2007;82(2):250.CrossRef Boateng F, Ohene-Adjei R, Amoateng-Adjepong Y. Rhabdomyolysis and acute renal failure associated with human granulocytic anaplasmosis. Mayo Clin Proc. 2007;82(2):250.CrossRef
12.
go back to reference Talsness SR, Shukla SK, Mazza JJ, Yale SH. Rhabdomyolysis-induced acute kidney injury secondary to Anaplasma phagocytophilum and concomitant statin use. WMJ. 2011;110(2):82–4.PubMed Talsness SR, Shukla SK, Mazza JJ, Yale SH. Rhabdomyolysis-induced acute kidney injury secondary to Anaplasma phagocytophilum and concomitant statin use. WMJ. 2011;110(2):82–4.PubMed
13.
go back to reference Heller HM, Telford SR, Branda JA. Case records of the Massachusetts General Hospital. Case 10–2005. A 73-year-old man with weakness and pain in the legs. N Engl J Med. 2005;352(13):1358–64.CrossRef Heller HM, Telford SR, Branda JA. Case records of the Massachusetts General Hospital. Case 10–2005. A 73-year-old man with weakness and pain in the legs. N Engl J Med. 2005;352(13):1358–64.CrossRef
15.
go back to reference Herráez García J, Torracchi Carrasco AM, Antolí-Royo AC, de la Fuente Blanco R, Santos Jiménez MT. Rhabdomyolysis. A descriptive study of 449 patients. Med Clin. 2012;139(6):238–42.CrossRef Herráez García J, Torracchi Carrasco AM, Antolí-Royo AC, de la Fuente Blanco R, Santos Jiménez MT. Rhabdomyolysis. A descriptive study of 449 patients. Med Clin. 2012;139(6):238–42.CrossRef
16.
go back to reference Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Critical care (London, England). 2016;20(1):135.CrossRef Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Critical care (London, England). 2016;20(1):135.CrossRef
17.
go back to reference Choi KS, Garyu J, Park J, Dumler JS. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun. 2003;71(8):4586–94.CrossRef Choi KS, Garyu J, Park J, Dumler JS. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun. 2003;71(8):4586–94.CrossRef
18.
go back to reference Dumler JS, Barat NC, Barat CE, Bakken JS. Human granulocytic anaplasmosis and macrophage activation. Clin Infect Dis. 2007;45(2):199–204.CrossRef Dumler JS, Barat NC, Barat CE, Bakken JS. Human granulocytic anaplasmosis and macrophage activation. Clin Infect Dis. 2007;45(2):199–204.CrossRef
Metadata
Title
Human granulocytic anaplasmosis combined with rhabdomyolysis: a case report
Authors
Jeong Min Cho
Jeonghyun Chang
Dong-Min Kim
Yee Gyung Kwak
Chong Rae Cho
Je Eun Song
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06869-z

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.